This does not alter our adherence to PLOS ONE policies on sharing data and materials. Pötter-Nerger received lecture fees from Abbott and Licher, and served as consultant for Medtronic, Boston scientific, Abbott and Abbvie. Gerloff reports honoraria from Bayer Healthcare, Boehringer Ingelheim, Acticor Biotech, Sanofi Aventis Amgene, and Prediction Bioscience. Koeppen reported no financial disclosures. Hamel received lecture fees and honoraria for serving on advisory boards and travel grants from Boston Scientific, Medtronic, and Abbott. Moll served as medico-scientific consultant to Abbott. Gulberti received travel reimbursements from Medtronic. Schaper reported no financial disclosures. Buhmann served on the scientific advisory boards for Bial and Zambon and received honoraria for lectures from Abbvie, Bial, GE Healthcare, Grünenthal, TAD and UCB. Zittel received research support from Merz Pharmeceuticals and honoraria from Brainlab AG. U.Hidding reported no financial disclosures. Vetorazzi reported no fincancial disclosures. Kirsten received travel and attendance grants from Abbott and Abbvie. Alsalem reported no financial disclosures. Gülke received travel and attendance grants from Abbvie, Abbott, Medtronic and Bial. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.Ĭompeting interests: I have read the journal’s policy and the authors of this manuscript have the following competing interests: E. This does not alter our adherence to PLOS ONE poli-cies on sharing data and materials. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.ĭata Availability: All relevant data are within the paper and its Supporting Information files.įunding: This work has been supported by the Deutsche Forschungsgemeinschaft (DFG) Sonderfor-schungsbereich (SFB) 936, project C8. Received: Accepted: FebruPublished: April 7, 2022Ĭopyright: © 2022 Gülke et al. PLoS ONE 17(4):Įditor: Mathias Toft, Oslo Universitetssykehus, NORWAY (2022) Comparison of Montreal cognitive assessment and Mattis dementia rating scale in the preoperative evaluation of subthalamic stimulation in Parkinson’s disease. Citation: Gülke E, Alsalem M, Kirsten M, Vettorazzi E, Choe C-u, Hidding U, et al.
0 kommentar(er)
